About Michael Teitell
Form D filings for MET Biotechnology in 2024 list Michael Teitell as director.
Michael Teitell first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Teitell in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Teitell works with at each company, as listed on that company's latest Form D.
MET Biotechnology Inc. · Form D, Feb 9, 2024
TW
Ting-Hsiang Wu
Chief Executive Officer and director
TW
Tung-Yu Wu
Chief Executive Officer and director
PC
Pei-Yu Chiou
Director